Natural Grocers by Vitamin Cottage, Inc. just released its fiscal 2025 fourth quarter and full-year results, reporting record sales and earnings. Compared to the fourth quarter of fiscal 2024, net sales increased by 4.2% to $336.1 million, with daily average comparable store sales also rising by 4.2%. Additionally, net income saw a significant 31.0% increase to $11.8 million, and adjusted EBITDA increased by 7.7% to $24.4 million.
For the full fiscal year 2025, the company experienced a 7.2% increase in net sales to $1.33 billion, with daily average comparable store sales rising by 7.3%. Net income for the year increased by 36.9% to $46.4 million, while adjusted EBITDA increased by 17.5% to $97.9 million. The company also opened two new stores and relocated/remodeled three stores during this period.
In terms of financial performance, the company reported $17.1 million in cash and cash equivalents as of September 30, 2025, with no outstanding borrowings on its $72.5 million revolving credit facility. During fiscal 2025, the company generated $55.3 million in cash from operations and invested $31.0 million in net capital expenditures, primarily for new and relocated/remodeled stores.
The company also announced a 25% increase in its quarterly cash dividend to $0.15 per common share, to be paid on December 10, 2025, to stockholders of record at the close of business on December 1, 2025.
Looking ahead to fiscal 2026, Natural Grocers by Vitamin Cottage, Inc. plans to open six to eight new stores and relocate/remodel two to three stores. Additionally, it expects daily average comparable store sales growth of 1.5% to 4.0% and diluted earnings per share of $2.00 to $2.15, with capital expenditures projected to be between $50 to $55 million.
This solid performance is attributed to the company's differentiated offering of high-quality, natural, and organic products, as well as its commitment to providing compelling value for customers. The company's strategy includes accelerated store growth and a balanced approach to capital allocation, which has resulted in strong fiscal 2025 operating performance and financial position. The market has reacted to these announcements by moving the company's shares -2.3% to a price of $30.64. Check out the company's full 8-K submission here.
